IFP Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5176 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4977 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4795 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4553 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4346 |
|
|
2020
Q2 | – | Sell |
-3,786
| Closed | -$27K | – | 4114 |
|
|
2020
Q1 | $27K | Buy |
3,786
+136
| +4% | +$970 | ﹤0.01% | 1376 |
|
|
2019
Q4 | $89K | Sell |
3,650
-72
| -2% | -$1.76K | 0.01% | 1006 |
|
|
2019
Q3 | $101K | Buy |
+3,722
| New | +$101K | 0.01% | 1056 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$2K | – | 3733 |
|
|
2018
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 3186 |
|
|
2018
Q3 | $3K | Sell |
100
-27
| -21% | -$810 | ﹤0.01% | 3441 |
|
|
2018
Q2 | $5K | Sell |
127
-3,073
| -96% | -$121K | ﹤0.01% | 3264 |
|
|
2018
Q1 | $156K | Hold |
3,200
| – | – | 0.01% | 1111 |
|
|
2017
Q4 | $156K | Hold |
3,200
| – | – | 0.01% | 1110 |
|
|
2017
Q3 | $173K | Buy |
3,200
+830
| +35% | +$44.9K | 0.01% | 1224 |
|
|
2017
Q2 | $133K | Buy |
2,370
+170
| +8% | +$9.54K | 0.01% | 1366 |
|
|
2017
Q1 | $86K | Sell |
2,200
-4,205
| -66% | -$164K | ﹤0.01% | 1580 |
|
|
2016
Q4 | $144K | Buy |
6,405
+2,100
| +49% | +$47.2K | 0.01% | 1220 |
|
|
2016
Q3 | $98K | Sell |
4,305
-13
| -0.3% | -$296 | 0.01% | 1371 |
|
|
2016
Q2 | $102K | Buy |
+4,318
| New | +$102K | 0.01% | 1326 |
|
|
2016
Q1 | – | Sell |
-2,247
| Closed | -$116K | – | 3763 |
|
|
2015
Q4 | $116K | Buy |
+2,247
| New | +$116K | 0.01% | 1096 |
|